Basilea Pharmaceutica Ag (OTC: BPMUF)
$44.45
(9.1%)
$3.70
Price as of April 10, 2024, 1:56 p.m. ET
Basilea Pharmaceutica Ag Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Basilea Pharmaceutica Ag Company Info
Basilea Pharmaceutica AG engages in the development and commercialization of pharmaceutical products. Its products include Cresemba, Zevtera, Derazantinib, BAL101553, and BAL3833. The company was founded on October 17, 2000 and is headquartered in Allschwil, Switzerland.
News & Analysis
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.